Literature DB >> 1877039

Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.

T J Torphy1, B J Undem.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1877039      PMCID： PMC463251          DOI： 10.1136/thx.46.7.512

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  84 in total

1.  Partial purification and characterization of cyclic nucleotide phosphodiesterases from human bronchial tissue.

Authors:  H Bergstrand; B Lundquist
Journal:  Mol Cell Biochem       Date:  1978-10-13       Impact factor: 3.396

Review 2.  Relationships between calcium and cyclic nucleotides in cell activation.

Authors:  H Rasmussen; D B Goodman
Journal:  Physiol Rev       Date:  1977-07       Impact factor: 37.312

Review 3.  Cyclic nucleotide phosphodiesterases.

Authors:  J N Wells; J G Hardman
Journal:  Adv Cyclic Nucleotide Res       Date:  1977

4.  Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline.

Authors:  J B Polson; J J Krzanowski; A L Goldman; A Szentivanyi
Journal:  Clin Exp Pharmacol Physiol       Date:  1978 Sep-Oct       Impact factor: 2.557

Review 5.  Modulation of inflammation and immunity by cyclic AMP.

Authors:  H R Bourne; L M Lichtenstein; K L Melmon; C S Henney; Y Weinstein; G M Shearer
Journal:  Science       Date:  1974-04-05       Impact factor: 47.728

6.  Intravenous salbutamol and aminophylline in asthma: a search for synergy.

Authors:  P D Handslip; A M Dart; B H Davies
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

7.  Histamine release in vitro: inhibition by catecholamines and methylxanthines.

Authors:  L M Lichtenstein; S Margolis
Journal:  Science       Date:  1968-08-30       Impact factor: 47.728

8.  Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function.

Authors:  R B Zurier; G Weissmann; S Hoffstein; S Kammerman; H H Tai
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

9.  The relationship between histamine secretion and 45calcium uptake by mast cells.

Authors:  J C Foreman; M B Hallett; J L Mongar
Journal:  J Physiol       Date:  1977-09       Impact factor: 5.182

10.  Immunological release of histamine and slow reacting substance of anaphylaxis from human lung.

Authors:  M Kaliner; R P Orange; K F Austen
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307
View more
  71 in total

Review 1.  Asthma: a follow up statement from an international paediatric asthma consensus group.

Authors: 
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

2.  The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation.

Authors:  K H Banner; E Moriggi; B Da Ros; G Schioppacassi; C Semeraro; C P Page
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.

Authors:  Claire Y Zhao; Joseph L Greenstein; Raimond L Winslow
Journal:  J Mol Cell Cardiol       Date:  2015-09-23       Impact factor: 5.000

4.  Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone.

Authors:  J E Souness; M E Villamil; L C Scott; A Tomkinson; M A Giembycz; D Raeburn
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

5.  Pulmonary effects of type V cyclic GMP specific phosphodiesterase inhibition in the anaesthetized guinea-pig.

Authors:  N C Turner; J S Dolan; D Grimsditch; J Lamb; A Worby; K J Murray; W J Coates; B H Warrington
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

6.  Effects of phosphodiesterase isoenzyme inhibitors on cutaneous inflammation in the guinea-pig.

Authors:  M M Teixeira; A G Rossi; T J Williams; P G Hellewell
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

7.  Relaxation of guinea-pig trachea by cyclic AMP phosphodiesterase inhibitors and their enhancement by sodium nitroprusside.

Authors:  N C Turner; J Lamb; A Worby; K J Murray
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

8.  Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram.

Authors:  J E Souness; C Maslen; S Webber; M Foster; D Raeburn; M N Palfreyman; M J Ashton; J A Karlsson
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

9.  Value of theophylline treatment in patients handicapped by chronic obstructive lung disease.

Authors:  S E McKay; C A Howie; A H Thomson; B Whiting; G J Addis
Journal:  Thorax       Date:  1993-03       Impact factor: 9.139

10.  Can the anti-inflammatory potential of PDE4 inhibitors be realized: guarded optimism or wishful thinking?

Authors:  M A Giembycz
Journal:  Br J Pharmacol       Date:  2008-07-28       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.